Trial Profile
A Study of Patients Treated With Ramipril for Cardiovascular Risk Reduction The HOPE Tips: The HOPE Study Translated Into PracticeS
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Ramipril (Primary)
- Indications Coronary artery disease
- Focus Adverse reactions
- Acronyms HOPETips
- Sponsors Sanofi
- 07 Apr 2017 New trial record